Honokiol

Independent reference data for Honokiol (CAS 35354-74-6), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Synonyms and trade names

Honokiol; 35354-74-6; 3,5'-Diallyl-4,2'-dihydroxybiphenyl; Purinol; FMLT BSASM H; DTXSID30188845; 4-allyl-2-(3-allyl-4-hydroxy-phenyl)phenol; 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol; 11513CCO0N; NSC-293100; (1,1'-BIPHENYL)-2,4'-DIOL, 3',5-DI-2-PROPEN-1-YL-; RefChem:788486; DTXCID90111336; 609-119-8; 5,3'-Diallyl-2,4'-dihydroxybiphenyl; NSC 293100

GHS hazard classification

Reported hazard statements	H302 (27.7%), H315 (27.7%), H318 (47.5%), H319 (52.5%), H335 (27.7%), H411 (36.6%)

H302 (27.7%): Harmful if swallowed [Warning Acute toxicity, oral]

H315 (27.7%): Causes skin irritation [Warning Skin corrosion/irritation]

What the public record says

Honokiol · CAS 35354-74-6 · C18H18O2. UNII 11513CCO0N.

Source: PubChem / Wikidata; the batch COA governs where values differ.